115
Participants
Start Date
October 14, 2020
Primary Completion Date
February 20, 2024
Study Completion Date
February 29, 2028
Genio™ system
The Genio™ device is a permanent implant. It is implanted in the chin area and delivers stimulation to both hypoglossal nerve branches (i.e., the left and right branches). The implant does not include a battery or an embedded software and is externally powered.
Wollongong Private Hospital, Wollongong
Universitair Ziekenhuis Antwerpen, Antwerp
Institute Breathing and Sleep Austin Hospital, Heidelberg
Hollywood Hospital, Nedlands
Weill Cornell Medicine Otolaryngology - Head and Neck Surgery, New York
Thomas Jefferson University Department of Otolaryngology, Philadelphia
Virginia Commonwealth University, Richmond
Advanced Ear Nose & Throat Associates, Atlanta
ENT and Allegy Associates South Florida, Boca Raton
University of South Florida-Tampa General Medical Center, Tampa
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
The University of Tennessee Health Science Center- Dept. of Otolaryngology, Memphis
Ohio Sleep Medicine Institute, Dublin
The Ohio State University, Wexner Medical Center, Columbus
CENTA (Center for ENT & Allergy), Carmel
University of Pennsylvania, Philadelphia
University of Iowa- Institute for Clinical & Translational Science, Iowa City
Medical College of Wisconsin, Milwaukee
Technische Universität München, München
Harvard/ Massachusetts Eye & Ear, Boston
Lead Sponsor
Collaborators (1)
Nyxoah Inc.
INDUSTRY
Nyxoah S.A.
INDUSTRY